Trial Profile
Exploratory phase IIa study of CPT in the treatment of multiple malignant solid tumors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2016
Price :
$35
*
At a glance
- Drugs Aponermin (Primary)
- Indications Colorectal cancer; Gastric cancer; Non-small cell lung cancer; Pancreatic cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 21 May 2012 Actual end date (31 Mar 2011) added as reported by Chinese Clinical Trial Register record.
- 18 Apr 2012 New trial record